Effects of Recombinant Human Growth Hormone in Children with Crohn’s Disease on the Muscle-Bone Unit: A Preliminary Study

20187 citationsJournal Articlegreen Open Access

Authors

Twenty-four months of therapy with rhGH in CD did not lead to an improvement in DXA BMD and lean mass, despite improvement in P1NP and linear growth.

Published in: Hormone Research in Paediatrics

Volume 90, Issue 2, pp. 128-131

Field-Weighted Citation Impact: 0.16